Netoglitazone: Antidiabetic PPARα/PPARγ agonist

Drugs of the Future

Volumn 27, Issue 2, 2002, Pages 132-139

  Sorbera, L A ^a   Castaner J ^a   Del Fresno, M ^a   Silvestre, J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL]ETHYLAMINO]BENZOIC ACID METHYL ESTER; 2 [4 [2 [3 (2,4 DIFLUOROPHENYL) 1 HEPTYLUREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; 5 (2,4 DIOXO 5 THIAZOLIDINYLMETHYL) 2 METHOXY N [4 (TRIFLUOROMETHYL)BENZYL]BENZAMIDE; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; CIGLITAZONE; CLX 0921; FARGLITAZAR; FENOFIBRATE; FK 614; GW 409544X; INSULIN; INSULIN RECEPTOR; MURAGLITAZAR; NETOGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; PIRINIXIC ACID; R 483; RAGAGLITAZAR; REGLITAZAR; RIVOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; TESAGLITAZAR; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; DIABETES MELLITUS; DRUG STRUCTURE; GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEPTOR BINDING; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0036254257     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2002.027.02.657482     Document Type: Article

References (47)

1. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
2. 2 is a ligand for the adipocyte determination factor PPARγ
3. A human peroxisome-proliferator-activated receptor-γ is activated by inducers of adipogenesis, including thiazolidinedione drugs
4. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ. Binding and activation correlate with antidiabetic actions in db/db mice
5. Isolation of the human peroxisome proliferator activated receptor γ cDNA: Expression in hematopoietic cells and chromosomal mapping
6. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
7. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
8. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids
9. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver
10. A unified nomenclature system for the nuclear receptor superfamily
11. The organization, promotor analysis, and expression of the human PPARγ gene
12. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARγ
13. PPARγ3 mRNA: A distinct PPARγ mRNA subtype transcribed from an independent promotor
14. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
15. 2 metabolite binds peroxisome proliferator-activated gamma and promotes adipocyte differentiation
16. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
17. The peroxisome proliferator activated receptor-γ is a negative regulator of macrophage activation
18. Convergence of 9 cis retinoic acids and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
19. The glitazone family of antidiabetic agents
20. The PPARs: From orphan receptors to drug discovery
21. Characterisation of a future generation insulin sensitizers in vitro and in vivo
22. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor γactivating properties
23. Characterization of a thiazolidinedione with PPARγ super agonist activity
24. The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes
25. Acute effect of MCC-555 in isolated hepatocytes of Otsuka Long-Evans Tokushima fatty rats
26. The thiazolidinedione, MCC-555, reduces ob expression in mature adipocytes, but does not alter plasma leptin concentrations
27. Effect of repeated administration of RWJ 241947/MCC-555, a novel insulin sensitizer, on serum lipoprotein levels in db/db mice
28. Comparative effects of thiazolidinediones on plasma glucose and triglycerides in a mouse model of diabetes
29. Hypoglycemic, hyperinsulinemia-improving and hypolipidemic effects of a novel insulin sensitizer in KK-A(Y) mice
30. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker diabetic fatty (ZDF) rats treated with the thiazolidinedione, MCC-555
31. The development of overt diabetes in young Zucker diabetic fatty (ZDF) rats and the effects of chronic MCC-555 treatment
32. The thiazolidinedione, MCC-555, prevents nitric oxide synthase induction in the pancreas of the Zucker diabetic fatty rat
33. The improving effect of MCC-555, an insulin sensitizer, on glucose tolerance in obese cynomolgus monkeys
34. MCC-555: A highly potent thiazolidinedione lacking hematological and cardiac side-effects
35. N-(2-Benzoylphenyl)-L- tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
36. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones
37. Novel tricyclic-α-alkyloxyphenylpropionic acids: Dual PPARα/γ agonists with hypolipidemic and antidiabetic activity
38. Novel benzoxazole 2,4 thiazolidinediones as potent hypoglycemic agents. Synthesis and structure activity relationships
39. Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents
40. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative
41. (-) DRF 2725, a novel dual activator of PPARα and PPARγ with unique antidiabetic hypolipidemic activity